Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Will there be a place for adoptive T-cell therapy in the checkpoint inhibitors?

Date

09 Oct 2016

Session

Will there be a place for adoptive T-cell therapy in the checkpoint inhibitors?

Presenters

Jacob Schachter

Authors

J. Schachter

Author affiliations

Ella Institute of Melanoma, Sheba Cancer Research Center, 52621 - Tel Hashomer/IL

More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login